#72 - Mast Cell Disease, the Hematologist & New Treatments on the Horizon episode artwork

EPISODE · Apr 17, 2024 · 33 MIN

#72 - Mast Cell Disease, the Hematologist & New Treatments on the Horizon

from The Itch: Allergies, Asthma, Eczema & Immunology · host The Itch: Allergies, Asthma & Immunology

Why talk to a hematologist about mast cell disease and systemic mastocytosis treatment? Dr. Douglas Tremblay, a leading hematologist, joins Dr. G and Kortney to discuss the role of a hematologist-oncologist in diagnosing and treating mastocytosis. We discuss bone marrow's vital role in diagnosing and treating systemic mastocytosis.  Dr. Tremblay discusses the latest KIT inhibitors, a promising group of medications, and explains the difference between indolent and advanced systemic mastocytosis. He clarifies how KIT inhibitors work and emphasizes the importance of managing side effects. Finally, Dr. Tremblay provides insights into the future of KIT inhibitor approval and explores the possibility of participating in a clinical trial for Bezulastinib.  What we cover in this episode about treating systemic mastocytosis: What is a hematologist looking at with mast cell disease patients? Mast cell diseases and the role of bone marrow Bone marrow biopsy for systemic mastocytosis  What is a bone marrow biopsy? Information bone marrow biopsy provides for diagnosis KIT mutation  KIT mutation testing in bone marrow and blood (digital droplet PCR) Indolent Mastocytosis versus Advanced Mastocytosis Current research for treating mast cell disease How KIT inhibitors work Do KIT inhibitors weaken the immune system? KIT Inhibitors discussed in this episode: Avapritinib Bezulastinib Elenestinib Are KIT inhibitors a cure for mast cell disease? Determining the tolerance for side effects of medications when researching and adding new medicines for diseases  The meaning of ‘NIB’ in the medication names The timeline for the new KIT inhibitors approval The type of patient that can participate in the clinical trials for Bezulastinib Resources about mast cell disease: Dr. Tremblay: https://profiles.mountsinai.org/douglas-a-tremblay Dr. Tremblay’s email: [email protected]  Mast Cell Disease Overview: https://allergyasthmanetwork.org/health-a-z/mast-cell-diseases/ What is Anaphylaxis? https://allergyasthmanetwork.org/anaphylaxis/ What is Epinephrine? https://allergyasthmanetwork.org/anaphylaxis/what-is-epinephrine/ The Mast Cell Disease Society: https://tmsforacure.org/ Current studies enrolling patients: https://tmsforacure.org/clinical-trials/

Episode metadata supplied by the publisher feed · Published Apr 17, 2024

Embed this episode

NOW PLAYING

#72 - Mast Cell Disease, the Hematologist & New Treatments on the Horizon

0:00 33:10

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Itch: Allergies, Asthma, Eczema & Immunology?

This episode is 33 minutes long.

When was this The Itch: Allergies, Asthma, Eczema & Immunology episode published?

This episode was published on April 17, 2024.

Can I download this The Itch: Allergies, Asthma, Eczema & Immunology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!